Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1990-9-12
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0165-6147
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
11
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
219-20
|
pubmed:dateRevised |
2005-11-16
|
pubmed:meshHeading |
pubmed-meshheading:2166367-Animals,
pubmed-meshheading:2166367-Glutamates,
pubmed-meshheading:2166367-Humans,
pubmed-meshheading:2166367-Receptors, Glutamate,
pubmed-meshheading:2166367-Receptors, N-Methyl-D-Aspartate,
pubmed-meshheading:2166367-Receptors, Neurotransmitter,
pubmed-meshheading:2166367-Schizophrenia
|
pubmed:year |
1990
|
pubmed:articleTitle |
Glutamate: a new target in schizophrenia?
|
pubmed:affiliation |
Department of Neuropsychopharmacology, Schering AG, Berlin, FRG.
|
pubmed:publicationType |
Journal Article,
Review
|